Antioxidant N-acetyl-L-cysteine increases engraftment of human hematopoietic stem cells in immune-deficient mice

Blood

Volumn 124, Issue 20, 2014, Pages e45-e48

  Hu, Linping ^a   Cheng, Hui ^a   Gao, Yingdai ^a   Shi, Ming ^a   Liu, Yanfeng ^a   Hu, Zheng ^b   Xu, Jing ^a   Qiu, Lugui ^a   Yuan, Weiping ^a   Leung, Anskar Yu Hung ^c   Yang, Yong Guang ^b,d   Cheng, Tao ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; TIBIA; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; NONOBESE DIABETIC MOUSE; PROCEDURES; SCID MOUSE; XENOGRAFT;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; BONE MARROW; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; REACTIVE OXYGEN SPECIES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84911944457     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-03-559369     Document Type: Article

References (13)

1. Dick JE, Lapidot T. Biology of normal and acute myeloid leukemia stem cells. Int J Hematol. 2005; 82(5):389-396.
2. Ito M, Hiramatsu H, Kobayashi K, et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175-3182.
3. Kollet O, Peled A, Byk T, et al. beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood. 2000;95(10):3102-3105.
4. McKenzie JL, Gan OI, Doedens M, Dick JE. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD1221 cells. Blood. 2005;106(4): 1259-1261.
5. Miao W, Xufeng R, Park MR, et al. Hematopoietic stem cell regeneration enhanced by ectopic expression of ROS-detoxifying enzymes in transplant mice. Mol Ther. 2013;21(2):423-432.
6. Shen H, Yu H, Liang PH, et al. An acute negative bystander effect of g-irradiated recipients on transplanted hematopoietic stem cells. Blood. 2012;119(15):3629-3637.
7. Ito K, Hirao A, Arai F, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004; 431(7011):997-1002.
8. Ito K, Hirao A, Arai F, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med. 2006;12(4): 446-451.
9. Jang YY, Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood. 2007;110(8):3056-3063.
10. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996;2(12):1329-1337.
11. McDermott SP, Eppert K, Lechman ER, Doedens M, Dick JE. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood. 2010;116(2):193-200.
12. Notta F, Doulatov S, Dick JE. Engraftment of human hematopoietic stem cells is more efficient in female NOD/SCID/IL-2Rgc-null recipients. Blood. 2010;115(18):3704-3707.
13. Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick JE. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science. 2011; 333(6039):218-221.